Sebastiaan LaBastide

Director of Innovation Roche Diabetes

Sebastiaan came to Roche a number of years ago from outside of health care. He has been heading up innovation incubation efforts at Roche ever since. Roche is one of the market leaders in diabetes treatment and also acquired Genentech, maker of some of the largest targeted therapeutics referenced in the introduction, in 2009. Genentech is known for its programs that make care more affordable for patients who need help accessing expensive treatments.